Non-invasive urine-based detection of PSMA-positive exosomes using a dual-aptamer electrochemical aptasensor for prostate cancer diagnosis
Microchimica Acta · 2026
DOI: 10.1007/s00604-025-07761-2 ↗Kurz gefasst
Fachartikel in der Zeitschrift Microchimica Acta, 2026. Verfasst von Emadoddin Amin-Sadrabadi und 1 weiteren Autor:innen. Beteiligte Einrichtung: Biosensor Research Center, Endocrinology and Metabolism Molecular- Cellular Sciences Institute, Tehran University of Medical Sciences, P.O. Box 14395…. Hauptthemen laut MEDLINE: Exosomes, Prostatic Neoplasms, Aptamers, Nucleotide, Glutamate Carboxypeptidase II. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 65 Literaturangaben.
Abstract (Originalsprache)
A novel electrochemical aptamer-based biosensor is reported for label-free detection of prostate-specific membrane antigen (PSMA)-positive exosomes in human urine. The platform integrates magnetic nanoparticles functionalized with CD63-specific aptamers (mMNPs) for efficient exosome capture, and screen-printed electrodes (SPEs) modified with carbon nanofibers (CNFs) and immobilized PSMA-specific aptamers for targeted detection. Differential pulse voltammetry (DPV), electrochemical impedance spectroscopy (EIS) and cyclic voltammetry (CV) confirmed the successful stepwise modification of the electrode surface and target recognition. The biosensor demonstrated excellent analytical performance for PSMA protein detection in exosome isolates, with a detection limit of 3 pg/mL and a linear response from 10 to 1400 pg/mL as quantified by ELISA. Specificity was confirmed using exosomes from PSMA-negative PC3 cell cultures and benign samples. Reproducibility and stability tests were conducted using exosomes isolated from the LNCaP cell culture, which confirmed operational robustness. Clinical urine testing showed high agreement with PSMA ELISA results, and urinary creatinine normalization improved data reliability across samples. This dual-aptamer biosensor offers a highly specific, reproducible, and non-invasive strategy for early prostate cancer diagnosis, with strong potential for point-of-care and clinical translation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Biosensor Research Center, Endocrinology and Metabolism Molecular- Cellular Sciences Institute, Tehran University of Medical Sciences, P.O. Box 14395/1179, Tehran, I.R, Iran.
- Biosensor Research Center, Endocrinology and Metabolism Molecular- Cellular Sciences Institute, Tehran University of Medical Sciences, P.O. Box 14395/1179, Tehran, I.R, Iran. omidfar@tums.ac.ir.
- Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Research Institute, Tehran University of Medical Sciences, Tehran, Iran. omidfar@tums.ac.ir.
Zitieren
APA
Amin-Sadrabadi, E., & Omidfar, K. (2026). Non-invasive urine-based detection of PSMA-positive exosomes using a dual-aptamer electrochemical aptasensor for prostate cancer diagnosis. Microchimica Acta. https://doi.org/10.1007/s00604-025-07761-2
Vancouver
Amin-Sadrabadi E, Omidfar K. Non-invasive urine-based detection of PSMA-positive exosomes using a dual-aptamer electrochemical aptasensor for prostate cancer diagnosis. Microchimica Acta. 2026. doi:10.1007/s00604-025-07761-2
BibTeX
@article{AminSadrabadi2026,
author = {Amin-Sadrabadi, Emadoddin and Omidfar, Kobra},
title = {Non-invasive urine-based detection of PSMA-positive exosomes using a dual-aptamer electrochemical aptasensor for prostate cancer diagnosis},
journal = {Microchimica Acta},
year = {2026},
doi = {10.1007/s00604-025-07761-2}
}
EUVIMED